Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 26, 2023

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Social Anxiety Disorder
Interventions
DRUG

Cannabidiol

Oral Capsule Formulation of CBD dissolved in a self-emulsifying drug technology called nanodomains, encapsulated within 1-ml softgel capsules, with a CBD purity ≥98%. Imported from Ananda Scientific

DRUG

Placebo

"Drug: Placebo~Placebo softgel capsule formulation."

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ananda Scientific

UNKNOWN

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

NYU Langone Health

OTHER

NCT05571592 - Cannabidiol as a Treatment for Social Anxiety Disorder (R61) | Biotech Hunter | Biotech Hunter